Statistics for Edwards Lifesciences (id:8566 EW)

Valuation metrics

Market cap

39.96B

Enterprise value

36.29B

Trailing P/E (ttm)

26.16

Forward P/E

27.66

PEG ratio

27.66

Price/Sales (ttm)

6.33

Price/Book (mrq)

4.19

Enterprise Value/Revenue

5.75

Enterprise Value/EBITDA

17.68

Overview

Shares outstanding

589.80M

Float

583.78M

Shares short

7.70M

% Held by insiders

0.01%

% Held by institutions

0.86%

Average volume (10 days)

4.60M

Average volume (90 days)

Price summary

52-Week low

58.93

52-Week high

96.12

52-Week change

2.36%

Beta

1.12

50-Day moving average

67.44

200-Day moving average

80.04

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

June 01th, 2020

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

65.86%

Operating margin

29.11%

Operational effectiveness

Return on assets

10.65%

Return on equity

19.14%

Income statement

Revenue (ttm)

10.50

Revenue per share (ttm)

10.50

Quarterly revenue growth (yoy)

6.98

Gross profit (ttm)

4.62B

EBITDA

1.79B

Net income to common (ttm)

1.57B

Diluted EPS (ttm)

2.59

Quarterly earnings growth (yoy)

697.80%

Balance sheet

Total cash (mrq)

4.45B

Total cash per share (mrq)

7.54

Total debt (mrq)

706.70M

Total Debt/Equity (mrq)

7.35

Current ratio (mrq)

346.10%

Book value per share (mrq)

16.18

Cash flow

Cash flow statement

806.40M

Levered free cash flow (LFCF)

1.79B